NASDAQ$BTTC

Black Titan Corp · Q4 2015 earnings

Q4 2015 earnings · · Investor relations

Headline financials

EPS (adj)

-$396.00

Previous: -$198.18-99.8%
Capital Expenditures

$77K

No prior period
Free Cash Flow

-$7.54M

No prior period
Net Income

-$2.29M

Previous: -$473K-385.0%
Operating Income

-$2.25M

Previous: -$1.25M-79.6%
Cash & Equivalents

$7.86M

No prior period
Total Assets

$13.3M

No prior period
Stock-Based Comp

$367K

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$0

Q2 2025
Beat estimate in 6 of 8 quarters(75%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro